1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HDHD2 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA IGSF9 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA ZSCAN23 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA SEPT3 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA CDC40 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA SYNCRIP CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA GALNT8 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA ZBTB24 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA CENPF CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA PCM1 CTRPv2 pan-cancer AAC 0.17 1e-06
Download CSV